VAM
IBB icon

Verity Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Verity Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,913
Closed -$279K – 204
2024
Q3 		$279K Buy
1,913
+55
+3% +$7.96K 0.1% 166
2024
Q2 		$255K Buy
+1,858
New +$248K 0.1% 159
2019
Q2 		– Sell
-5,278
Closed -$590K – 131
2019
Q1 		$590K Buy
+5,278
New +$579K 0.68% 40
2018
Q2 		– Sell
-21,146
Closed -$2.26M – 123
2018
Q1 		$2.26M Sell
21,146
-5,386
-20% -$597K 2.06% 8
2017
Q4 		$3.03M Buy
26,532
+66
+0.2% +$7.05K 2.28% 8
2017
Q3 		$2.77M Sell
26,466
-4,341
-14% -$464K 2.11% 11
2017
Q2 		$3.18M Sell
30,807
-2,862
-9% -$282K 2.39% 10
2017
Q1 		$3.29M Buy
+33,669
New +$3.22M 2.72% 6
2016
Q3 		$3.75M Sell
38,850
-933
-2% -$88.8K 3.49% 4
2016
Q2 		$3.41M Sell
39,783
-774
-2% -$69.4K 3.38% 5
2016
Q1 		$3.53M Sell
40,557
-35,673
-47% -$3.19M 3.99% 3
2015
Q4 		$8.6M Buy
76,230
+3,183
+4% +$345K 9.89% 1
2015
Q3 		$7.39M Buy
73,047
+16,053
+28% +$1.93M 7.39% 1
2015
Q2 		$7.01M Sell
56,994
-792
-1% -$94.8K 6.35% 1
2015
Q1 		$6.62M Sell
57,786
-4,326
-7% -$477K 6.43% 2
2014
Q4 		$6.28M Sell
62,112
-33,105
-35% -$3.22M 6.06% 2
2014
Q3 		$8.68M Sell
95,217
-34,974
-27% -$3.07M 9.77% 1
2014
Q2 		$11.2M Buy
130,191
+768
+0.6% +$60.5K 12.14% 1
2014
Q1 		$10.4M Sell
129,423
-9,564
-7% -$797K 10.7% 1
2013
Q4 		$10.5M Buy
+138,987
New +$9.86M 11.49% 1

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Verity Asset Management's IBB Position: Q4 2024 in Review

Verity Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,913 shares — an estimated $279K sold.

Verity Asset Management first reported a position in IBB in Q4 2013 and held it in 20 quarters. The position peaked at $11.2M in Q2 2014. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Verity Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Verity Asset Management sold 1,913 iShares Biotechnology ETF shares in Q4 2024, an estimated $279K.
  • Verity Asset Management first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 20 quarters.
  • Verity Asset Management's iShares Biotechnology ETF position peaked at $11.2M in Q2 2014.
  • 875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Verity Asset Management's 13F filing for Q4 2024, filed 27 Jan 2025.